Pro-Dex Inc is engaged in the design, development, manufacture, sale and repair of handheld medical devices and accessories, with products including Powered Surgical Drivers, Precision Air Powered Motors and others, including autoclavable, battery-powered and electric multi-function surgical drivers and shavers used mainly in the orthopedic, thoracic and craniomaxillofacial markets, as well as providing engineering, quality, regulatory consulting, NRE and prototype services, and manufacturing and selling rotary air motors and precision machined parts and assemblies for the aerospace and defense industries, with the majority of revenue derived from designing, developing, manufacturing and repairing powered surgical instruments for medical device original equipment manufacturers.
Last trade$63.77
Day change-$0.715 (-1.11%)
Day range$61.96 – $65.71
Volume14,837
Market cap$206M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$206.34M
Price / earnings
17.15×
Price / book
4.18×
Price / sales
2.59×
EV / sales
2.65×
EV / EBITDA
14.18×
Profitability
Earnings per share
$3.76
Return on assets
15.71%
Return on equity
24.38%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.33×
Current ratio
4.19×
Quick ratio
2.49×
Cash ratio
0.91×
Cash flow
Price / cash flow
18.06×
Price / free cash flow
19.3×
Free cash flow
$10.69M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for PDEX, quarterly periods
Line item
Q1 FY2027 Sep 30, 2026
Q4 FY2026 Jun 30, 2026
Q3 FY2026 Mar 31, 2026
Q2 FY2026 Dec 31, 2025
Q1 FY2026 Sep 30, 2025
Q4 FY2025 Jun 30, 2025
Q3 FY2025 Mar 31, 2025
Q2 FY2025 Dec 31, 2024
Revenue
$20.56M
$20.41M
$19.95M
$18.66M
$18.53M
$17.49M
$17.41M
$16.79M
Cost of revenue
$13.7M
$13.31M
$13.82M
$12.92M
$13.16M
$14M
$11.62M
$11.72M
Gross profit
$6.86M
$7.09M
$6.13M
$5.74M
$5.37M
$3.49M
$5.8M
$5.07M
Selling, general and administrative
$2.13M
$2.55M
$2.21M
$1.75M
$1.49M
$1.24M
$1.21M
$1.44M
Research and development
$1.21M
$1.02M
$827K
$734K
$768K
$905K
$947K
$942K
Total operating expenses
$3.34M
$3.56M
$3.04M
$2.48M
$2.26M
$2.15M
$2.16M
$2.38M
Operating income
$3.52M
$3.53M
$3.09M
$3.26M
$3.11M
$1.34M
$3.64M
$2.69M
Interest expense
-$260K
-$270K
-$201K
-$141K
-$200K
-$227K
-$246K
-$204K
Income before taxes
$3.38M
$3.53M
$5.34M
$2.93M
$6.22M
$1.6M
$4.55M
$2.59M
Income taxes
$331K
$668K
$1.4M
$741K
$1.54M
$402K
$1.28M
$546K
Net income
$3.05M
$2.86M
$3.94M
$2.19M
$4.68M
$1.2M
$3.28M
$2.04M
Net income attributable to common shareholders
$3.05M
$2.86M
$3.94M
$2.19M
$4.68M
$1.2M
$3.28M
$2.04M
EBITDA
$3.92M
$3.94M
$3.46M
$3.57M
$3.42M
$1.66M
$3.95M
$3.01M
Basic earnings per share
$0.95
$0.90
$1.23
$0.67
$1.43
$0.36
$1.00
$0.63
Diluted earnings per share
$0.92
$0.85
$1.20
$0.66
$1.40
$0.34
$0.98
$0.61
Recent news
Company coverage with links to the original publishers.
Pro-Dex (PDEX) reported Q3 earnings of $0.92 per share, beating consensus estimates by 37.31%, with revenues of $20.56 million. The company has outperformed the S&P 500 by 64.2% year-to-date and received a Zacks Rank #1 (Strong Buy) rating. However, the Medical-Dental Supplies industry ranks in the bottom 32% of Zacks industries, which could limit future performance.
ProDex is expected to report Q1 fiscal 2027 earnings with consensus estimates of 67 cents per share (8.1% YoY growth) and $20.4M in revenues (10.1% increase). While the company showed strong Q4 results with 17% sales growth and improved 35% gross margins, investors will focus on sustainability amid high customer concentration (78% from largest customer), declining backlog, and risks from the recent Advanced Precision Machining acquisition integration.
The Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, and technology adoption, with the global market expected to reach $318.77 billion by 2031. However, tariffs, commodity inflation, and policy-driven pricing changes present headwinds. Five key stocks—McKesson, Cardinal Health, Becton Dickinson, Merit Medical Systems, and ProDex—are highlighted as well-positioned to capitalize on favorable industry trends through 2026.
The Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, AI automation, and aging demographics. The global medical supplies market is expected to reach $318.77 billion by 2031 with a 10% CAGR. However, tariffs, commodity inflation, and pharmaceutical pricing changes remain headwinds. Key industry players show mixed near-term prospects with the industry trading at favorable valuations compared to broader markets.
The article highlights the performance and outlook of Toyota Motor, Lockheed Martin, Chubb, and Pro-Dex. It discusses the companies' strengths, challenges, and growth strategies.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.